[EN] NOVEL COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY<br/>[FR] NOUVEAUX COMPOSÉS COMME MODULATEURS DE RÉCEPTEURS PRÉSENTANT UNE UTILITÉ THÉRAPEUTIQUE
申请人:ALLERGAN INC
公开号:WO2011066179A1
公开(公告)日:2011-06-03
The present invention relates to novel cyclic amine and cycloalkyl derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine- 1 -phosphate receptors.
Highly Enantioselective Direct Alkylation of Arylacetic Acids with Chiral Lithium Amides as Traceless Auxiliaries
作者:Craig E. Stivala、Armen Zakarian
DOI:10.1021/ja205107x
日期:2011.8.10
A direct, highly enantioselective alkylation of arylacetic acids via enediolates using a readily available chiral lithium amide as a stereodirecting reagent has been developed. This approach circumvents the traditional attachment and removal of chiralauxiliaries used currently for this type of transformation. The protocol is operationally simple, and the chiral reagent is readily recoverable.
NOVEL COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY
申请人:Allergan, Inc.
公开号:EP2504328A1
公开(公告)日:2012-10-03
Acyclic phenylalkanediols as substrates for the study of enzyme recognition: synthesis of substrates and enzymatic resolution via hydrolysis and transesterification
作者:Angel Rumbero、Isabel Borreguero、José V. Sinisterra、Andrés R. Alcántara
DOI:10.1016/s0040-4020(99)00941-2
日期:1999.12
diacetates, in both cases catalysed by porcine pancreatic lipase (PPL). The absolute configuration of the optically enriched reaction products was determined by formation of Mosher's esters or by the use of the BenzeneSector and Benzene Chirality Rules as obtained from the CircularDichroism spectra.
Molecular modification of anticholinergics as probes for muscarinic receptors. 1. Amino esters of .alpha.-substituted phenylacetic acid and related analogs
作者:Matthias C. Lu、Walley E. Wung、Lisa B. Shih、Soledad Callejas、James E. Gearien、Emmanuel B. Thompson
DOI:10.1021/jm00385a008
日期:1987.2
Two series of compounds having the general structure of C6H5CRR'COOCH2CH2NEt2 were synthesized and examined for their antispasmodic activities. These compounds were selected as structural probes for exploring the nature of muscarinic cholinergic receptor binding sites that interact with atropine-like anticholinergics. These studies indicate a rather strict size limitation for the hydrophobic region